- Home
- EVF vs IPA Comparison
EVF vs IPA Comparison
Compare EVF & IPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVF
- IPA
- Stock Information
- Founded
- EVF 1998
- IPA 1983
- Country
- EVF United States
- IPA United States
- Employees
- EVF N/A
- IPA N/A
- Industry
- EVF Investment Managers
- IPA Biotechnology: Pharmaceutical Preparations
- Sector
- EVF Finance
- IPA Health Care
- Exchange
- EVF Nasdaq
- IPA Nasdaq
- Market Cap
- EVF 100.4M
- IPA 98.9M
- IPO Year
- EVF N/A
- IPA 2017
- Fundamental
- Price
- EVF $5.55
- IPA $3.20
- Analyst Decision
- EVF
- IPA Strong Buy
- Analyst Count
- EVF 0
- IPA 2
- Target Price
- EVF N/A
- IPA $4.00
- AVG Volume (30 Days)
- EVF 93.3K
- IPA 1.7M
- Earning Date
- EVF 01-01-0001
- IPA 09-15-2025
- Dividend Yield
- EVF 10.68%
- IPA N/A
- EPS Growth
- EVF N/A
- IPA N/A
- EPS
- EVF 0.94
- IPA N/A
- Revenue
- EVF N/A
- IPA $17,744,713.00
- Revenue This Year
- EVF N/A
- IPA $19.47
- Revenue Next Year
- EVF N/A
- IPA $32.09
- P/E Ratio
- EVF $6.74
- IPA N/A
- Revenue Growth
- EVF N/A
- IPA 0.01
- 52 Week Low
- EVF $5.20
- IPA $0.27
- 52 Week High
- EVF $6.84
- IPA $3.20
- Technical
- Relative Strength Index (RSI)
- EVF 43.15
- IPA 72.09
- Support Level
- EVF $5.49
- IPA $1.82
- Resistance Level
- EVF $5.63
- IPA $2.12
- Average True Range (ATR)
- EVF 0.03
- IPA 0.28
- MACD
- EVF 0.00
- IPA 0.10
- Stochastic Oscillator
- EVF 50.00
- IPA 99.32
About EVF Eaton Vance Senior Income Trust
Eaton Vance Senior Income Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to provide a high level of current income consistent with the preservation of capital, by investing in senior, secured floating-rate loans. The trust invests in below-investment-grade floating-rate loans, which are considered speculative because of the credit risk of their issuers. Its portfolio of investment consists of aerospace and defense, automotive, beverage, building and development, business equipment and services, cable and satellite television, and other areas.
About IPA ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Antibodies Ltd is a techbio company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges. IPA has several subsidiaries in North America and Europe.